Puma Biotechnology (PBYI) Other Accumulated Expenses (2011 - 2026)
Puma Biotechnology (PBYI) reported Other Accumulated Expenses of $353000.0 for Q1 2026, up 33.71% on a YoY basis from $264000.0 in Q1 2025, and up 148.59% quarter-over-quarter from $142000.0 in Q4 2025.
Puma Biotechnology (PBYI) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Puma Biotechnology has reported Other Accumulated Expenses for 16 years, with the latest figure at $353000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 33.71% year-over-year to $353000.0; the trailing twelve-month figure through Mar 2026 stood at $353000.0 (up 33.71% YoY), and the FY2025 full-year result was $142000.0, changed N/A from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $353000.0, up from $142000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $619000.0 in Q1 2024, with the low at $81000.0 in Q3 2024.
- Historically, Other Accumulated Expenses has averaged $292812.5 across 5 years, with a median of $264000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses jumped 138.6% — and 2024, when it plunged 69.32%.
- Puma Biotechnology's Other Accumulated Expenses stood at $215000.0 in 2022, then jumped by 138.6% to $513000.0 in 2023, then sank by 84.21% to $81000.0 in 2024, then soared by 75.31% to $142000.0 in 2025, then soared by 148.59% to $353000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $353000.0 (Q1 2026), $142000.0 (Q4 2025), and $171000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353,000.00 |
| Dec 31, 2025 | 142,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 264,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 316,000.00 |
| Mar 31, 2024 | 619,000.00 |
| Dec 31, 2023 | 513,000.00 |
| Sep 30, 2023 | 264,000.00 |
| Jun 30, 2023 | 330,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 215,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 252,000.00 |
| Mar 31, 2022 | 437,000.00 |
| Dec 31, 2021 | 632,000.00 |
| Sep 30, 2021 | 579,000.00 |
| Jun 30, 2021 | 733,000.00 |
| Mar 31, 2021 | 589,000.00 |